Aintzane Apraiz

Aintzane Apraiz

Auto-generated profile, based on publicly available information

Aintzane Apraiz

Department of Cell Biology and Histology Faculty of Medicine and Nursing Leioa Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2011 in Apoptosis
Verified
Journal Article
Open access
PDF file
FNFrancesca Nicolau-Galmés
Francesca Nicolau-Galmés
AAAintzane Asumendi
Aintzane Asumendi
EAErika Alonso-Tejerina
Erika Alonso-Tejerina
GPGorka Pérez-Yarza
Gorka Pérez-Yarza
SJShawkat-Muhialdin Jangi
Shawkat-Muhialdin Jangi
MBMaría Dolores Boyano
María Dolores Boyano
Previously we found that terfenadine, an H1 histamine receptor antagonist, acts as a potent apoptosis inducer in melanoma cells through modulation of Ca2+ homeostasis. In this report, focusing our attention on the apoptotic mechanisms activated by terfenadine, we show that this drug can potentially activate distinct intrinsic signaling pathways depending on culture conditions. Serum-deprived conditions enhance the cytotoxic effect of terfenadine and caspase-4 and -2 are activated upstream of caspase-9. Moreover, although we found an increase in ROS levels, the apoptosis was ROS independent. Conversely, terfenadine treatment in complete medium induced ROS-dependent apoptosis. Caspase-4, -2, and -9 were simultaneously activated and p73 and Noxa induction were involved. ROS inhibition prevented p73 and Noxa expression but not p53 and p21 expression, suggesting a role for Noxa in p53-independent apoptosis in melanoma cells. Finally, we found that terfenadine induced autophagy, that can promote apoptosis. These findings demonstrate the great potential of terfenadine to kill melanoma cells through different cellular signaling pathways and could contribute to define new therapeutic strategies in melanoma.

1 March 2009 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
NNN. Nieto‐Rementería
N. Nieto‐Rementería
GPG. Pérez‐Yarza
G. Pérez‐Yarza
MBM D Boyano
M D Boyano
AAA. Apraiz
A. Apraiz
RIR. Izu
R. Izu
AAAintzane Asumendi
Aintzane Asumendi

12 September 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
ULUsua Laresgoiti
Usua Laresgoiti
AAAintzane Apraiz
Aintzane Apraiz
MOMiguel Olea
Miguel Olea
JMJone Mitxelena
Jone Mitxelena
NONerea Osinalde
Nerea Osinalde
Ana María ZubiagaAna María Zubiaga
Ana María Zubiaga
E2F2 is essential for the maintenance of T lymphocyte quiescence. To identify the full set of E2F2 target genes, and to gain further understanding of the role of E2F2 in transcriptional regulation, we have performed ChIP-chip analyses across the genome of lymph node–derived T lymphocytes. Here we show that during quiescence, E2F2 binds the promoters of a large number of genes involved in DNA metabolism and cell cycle regulation, concomitant with their transcriptional silencing. A comparison of ChIP-chip data with expression profiling data on resting E2f2−/− T lymphocytes identified a subset of 51 E2F2-specific target genes, most of which are upregulated on E2F2 loss. Luciferase reporter assays showed a retinoblastoma-independent role for E2F2 in the negative regulation of these target genes. Importantly, we show that the DNA binding activity of the transcription factor CREB contributes to E2F2-mediated repression of Mcm5 and Chk1 promoters. siRNA-mediated CREB knockdown, expression of a dominant negative KCREB mutant or disruption of CREB binding by mutating a CRE motif on Mcm5 promoter, relieved E2F2-mediated transcriptional repression. Taken together, our data uncover a new regulatory mechanism for E2F-mediated transcriptional control, whereby E2F2 and CREB cooperate in the transcriptional repression of a subset of E2F2 target genes.

29 March 2010 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
JIJolanta Idkowiak-Baldys
Jolanta Idkowiak-Baldys
AAAintzane Apraiz
Aintzane Apraiz
LLLi Li
Li Li
MRMehrdad Rahmaniyan
Mehrdad Rahmaniyan
CCChristopher J. Clarke
Christopher J. Clarke
YHYusuf Hannun
Yusuf Hannun
Oxidative stress has been implicated previously in the regulation of ceramide metabolism. In the present study, its effects on dihydroceramide desaturase were investigated. To stimulate oxidative stress, HEK (human embyronic kidney)-293, MCF7, A549 and SMS-KCNR cells were treated with H2O2, menadione or tert-butylhydroperoxide. In all cell lines, an increase in dihydroceramide was observed upon oxidative stress as measured by LC (liquid chromatography)/MS. In contrast, total ceramide levels were relatively unchanged. Mechanistically, dihydroceramide desaturase activity was measured by an in situ assay and decreased in a time- and dose-dependent fashion. Interestingly, no detectable changes in the protein levels were observed, suggesting that oxidative stress does not induce degradation of dihydroceramide desaturase. In summary, oxidative stress leads to potent inhibition of dihydroceramide desaturase resulting in significant elevation in dihydroceramide levels in vivo.

9 March 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JMJone Mitxelena
Jone Mitxelena
AAAintzane Apraiz
Aintzane Apraiz
JVJon Vallejo-Rodríguez
Jon Vallejo-Rodríguez
MMMarcos Malumbres
Marcos Malumbres
Ana María ZubiagaAna María Zubiaga
Ana María Zubiaga
E2F transcription factors (E2F1-8) are known to coordinately regulate the expression of a plethora of target genes, including those coding for microRNAs (miRNAs), to control cell cycle progression. Recent work has described the atypical E2F factor E2F7 as a transcriptional repressor of cell cycle-related protein-coding genes. However, the contribution of E2F7 to miRNA gene expression during the cell cycle has not been defined. We have performed a genome-wide RNA sequencing analysis to identify E2F7-regulated miRNAs and show that E2F7 plays as a major role in the negative regulation of a set of miRNAs that promote cellular proliferation. We provide mechanistic evidence for an interplay between E2F7 and the canonical E2F factors E2F1-3 in the regulation of multiple miRNAs. We show that miR-25, -26a, -27b, -92a and -7 expression is controlled at the transcriptional level by the antagonistic activity of E2F7 and E2F1-3. By contrast, let-7 miRNA expression is controlled indirectly through a novel E2F/c-MYC/LIN28B axis, whereby E2F7 and E2F1-3 modulate c-MYC and LIN28B levels to impact let-7 miRNA processing and maturation. Taken together, our data uncover a new regulatory network involving transcriptional and post-transcriptional mechanisms controlled by E2F7 to restrain cell cycle progression through repression of proliferation-promoting miRNAs.

1 April 2012 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
AAAintzane Apraiz
Aintzane Apraiz
JIJolanta Idkowiak-Baldys
Jolanta Idkowiak-Baldys
NNNaiara Nieto-Rementería
Naiara Nieto-Rementería
MBMaría Dolores Boyano
María Dolores Boyano
YHYusuf A Hannun
Yusuf A Hannun
AAAintzane Asumendi
Aintzane Asumendi
4-(Hydroxyphenyl)retinamide (4-HPR) is a synthetic retinoid with a strong apoptotic effect towards different cancer cell lines in vitro, and it is currently tested in clinical trials. Increases of reactive oxygen species (ROS) and modulation of endogenous sphingolipid levels are well-described events observed upon 4-HPR treatment, but there is still a lack of understanding of their relationship and their contribution to cell death. LC–MS analysis of sphingolipids revealed that in human leukemia CCRF-CEM and Jurkat cells, 4-HPR induced dihydroceramide but not ceramide accumulation even at sublethal concentrations. Myriocin prevented the 4-HPR-induced dihydroceramide accumulation, but it did not prevent the loss of viability and increase of intracellular ROS production. On the other hand, ascorbic acid, Trolox, and vitamin E reversed 4-HPR effects on cell death but not dihydroceramide accumulation. NDGA, described as a lipoxygenase inhibitor, exerted a significantly higher antioxidant activity than vitamin E and abrogated 4-HPR-mediated ROS. It did not however rescue cellular viability. Taken together, this study demonstrates that early changes observed upon 4-HPR treatment, i.e., sphingolipid modulation and ROS production, are mechanistically independent events. Furthermore, the results indicate that 4-HPR-driven cell death may occur even in the absence of dihydroceramide or ROS accumulation. These observations should be taken into account for an improved design of drug combinations.